MGMT and glioblastoma: The status of O‐6‐methylguanine DNA methyltransferase (MGMT) promoter methylation is a critical prognostic factor in glioblastoma, as its methylation is associated with better response to alkylating agents like temozolomide, improving the overall survival.3